Caisse Des Depots Et Consignations’s Edwards Lifesciences EW Stock Holding History

Caisse Des Depots Et Consignations’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.82M	Hold	42,257	–	–	0.06%	95
2026 Q1	$3.38M	Sell	42,257 -9,509	-18%	-$784K	0.06%	92
2025 Q4	$4.41M	Sell	51,766 -12,427	-19%	-$1.02M	0.1%	85
2025 Q3	$4.99M	Sell	64,193 -4,197	-6%	-$328K	0.21%	73
2025 Q2	$5.35M	Sell	68,390 -3,831	-5%	-$286K	0.22%	76
2025 Q1	$5.23M	Sell	72,221 -4,021	-5%	-$288K	0.25%	72
2024 Q4	$5.64M	Buy	+76,242	New	+$5.34M	0.28%	57

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Caisse Des Depots Et Consignations's EW Position: Q2 2026 in Review

Caisse Des Depots Et Consignations held its Edwards Lifesciences (EW) position steady in Q2 2026 at 42,257 shares worth $3.82M. The position accounts for 0.06% of the portfolio, ranked #95.

Caisse Des Depots Et Consignations first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.64M in Q4 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Caisse Des Depots Et Consignations held 42,257 shares of Edwards Lifesciences worth $3.82M as of Q2 2026.
Caisse Des Depots Et Consignations left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.06% of Caisse Des Depots Et Consignations's portfolio in Q2 2026, its #95 holding.
Caisse Des Depots Et Consignations first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
Caisse Des Depots Et Consignations's Edwards Lifesciences position peaked at $5.64M in Q4 2024.
1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Caisse Des Depots Et Consignations's 13F filing for Q2 2026, filed 24 Jul 2026.